Pharmacokinetics and stability of the ch14.18–interleukin-2 fusion protein in mice Kari KendraJacek GanPaul M. Sondel ORIGINAL ARTICLE Pages: 219 - 229
Induction of antitumor immunity after cure of pulmonary metastases, using staphylococcal enterotoxin B and bispecific antibody David C. RiceAndrei I. ChapovalHeidi Nelson ORIGINAL ARTICLE Pages: 230 - 238
Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones Alexei F. KirkinPer thor StratenJesper Zeuthen ORIGINAL ARTICLE Pages: 239 - 246
Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2 Karen S. ZierSilvia Salvadori ORIGINAL ARTICLE Pages: 247 - 252
On down-regulation of the immune response to metastatic malignant melanoma Annika HåkanssonBertil GustafssonLeif Håkansson ORIGINAL ARTICLE Pages: 253 - 262
Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy Jan W. GratamaArnold H. ZeaAugusto C. Ochoa ORIGINAL ARTICLE Pages: 263 - 269
Immunoregulation in pancreatic cancer patients Janet M. D. PlateSusan ShottJules E. Harris ORIGINAL ARTICLE Pages: 270 - 279